KAUST's Laboratory of Stem Cells and Diseases, led by Assistant Professor Antonio Adamo, uses induced pluripotent stem cells (iPSCs) to model diseases like diabetes. The lab employs a reprogramming technique to revert patient fibroblasts into iPSCs, enabling the study of disease progression in vitro. Adamo's research focuses on enzymes and disregulated transcriptional/epigenetic mechanisms to understand disease onset. Why it matters: This research contributes to regenerative medicine and offers insights into metabolic diseases relevant to the GCC region.
The Russian Immune Diversity Atlas project aims to profile immune cells from people of different ancestries at a multiomics level. The goal is to reconstruct a reference atlas of the healthy immune system and investigate its perturbations in Type II Diabetes (T2D). The project seeks to identify novel mechanisms and genetic/epigenetic markers for early T2D diagnostics, prognosis, and therapy as part of the international Human Cell Atlas. Why it matters: Addressing genetic diversity in biomedical research, particularly in the context of the Human Cell Atlas, is crucial for personalized medicine and ensuring that treatments are effective across diverse populations in the Middle East and globally.
MBZUAI is developing AI algorithms to intelligently process data from wearables and home sensors for remote patient monitoring. The algorithms aim to analyze multiple strands of health data to provide a more comprehensive view of a patient's health, distinguishing between genuine emergencies and benign situations. MBZUAI's provost, Professor Fakhri Karray, believes this approach could handle 20-25% of diagnoses virtually, reducing the burden on healthcare systems. Why it matters: This research could significantly improve healthcare efficiency and accessibility in the UAE and beyond by enabling more effective remote patient monitoring and reducing unnecessary hospital visits.
KAUST and Saudi healthtech company amplifAI health have signed an MoU to develop a new disease detection system. The system will combine amplifAI's AI technology with KAUST's HyplexTM hyperspectral imaging, initially for diabetic foot complications. Clinical trials are planned, with aims to reduce amputations and save Saudi Arabia over 2 billion Riyals annually. Why it matters: This partnership showcases the potential of combining Saudi AI and advanced imaging technologies to address pressing healthcare challenges in the region, particularly diabetes.
The Technology Innovation Institute (TII) in Abu Dhabi has launched a 2-micrometer high-power fiber laser for medical and industrial applications. Developed by TII's Directed Energy Research Center, the Thulium-based laser is efficient, compact, and scalable, enabling precise interaction with water-rich materials. TII has partnered with LIMA Photonics, a German MedTech startup, to integrate the laser into clinical solutions, including urinary stone treatment and prostate surgery. Why it matters: This laser technology and partnership showcase the UAE's commitment to translating advanced research into healthcare solutions, positioning Abu Dhabi as a hub for medical technology innovation.
KAUST researchers found Y-series nonfullerene acceptors enhance the outdoor stability of organic solar cells, enabling energy-efficient windows. They also used satellite data to show managed vegetation can mitigate rising temperatures across Saudi Arabia's agricultural regions. Additionally, they developed DeepKriging, a deep neural network, to solve complex spatiotemporal datasets and tested it on air pollution. Why it matters: This research addresses critical challenges in renewable energy, climate change, and AI data privacy relevant to Saudi Arabia and the broader region.